These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 34716408)

  • 21. Pronociceptive and antinociceptive effects of estradiol through endogenous opioid neurotransmission in women.
    Smith YR; Stohler CS; Nichols TE; Bueller JA; Koeppe RA; Zubieta JK
    J Neurosci; 2006 May; 26(21):5777-85. PubMed ID: 16723535
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Expectancy Modulation of Opioid Neurotransmission.
    Pecina M; Zubieta JK
    Int Rev Neurobiol; 2018; 138():17-37. PubMed ID: 29681324
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Smoking modulation of mu-opioid and dopamine D2 receptor-mediated neurotransmission in humans.
    Scott DJ; Domino EF; Heitzeg MM; Koeppe RA; Ni L; Guthrie S; Zubieta JK
    Neuropsychopharmacology; 2007 Feb; 32(2):450-7. PubMed ID: 17091130
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Low μ-Opioid Receptor Status in Alcohol Dependence Identified by Combined Positron Emission Tomography and Post-Mortem Brain Analysis.
    Hermann D; Hirth N; Reimold M; Batra A; Smolka MN; Hoffmann S; Kiefer F; Noori HR; Sommer WH; Reischl G; la Fougère C; Mann K; Spanagel R; Hansson AC
    Neuropsychopharmacology; 2017 Feb; 42(3):606-614. PubMed ID: 27510425
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Neurotransmitters behind pain relief with transcranial magnetic stimulation - positron emission tomography evidence for release of endogenous opioids.
    Lamusuo S; Hirvonen J; Lindholm P; Martikainen IK; Hagelberg N; Parkkola R; Taiminen T; Hietala J; Helin S; Virtanen A; Pertovaara A; Jääskeläinen SK
    Eur J Pain; 2017 Oct; 21(9):1505-1515. PubMed ID: 28493519
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Alterations in endogenous opioid functional measures in chronic back pain.
    Martikainen IK; Peciña M; Love TM; Nuechterlein EB; Cummiford CM; Green CR; Harris RE; Stohler CS; Zubieta JK
    J Neurosci; 2013 Sep; 33(37):14729-37. PubMed ID: 24027273
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Traditional Chinese acupuncture and placebo (sham) acupuncture are differentiated by their effects on mu-opioid receptors (MORs).
    Harris RE; Zubieta JK; Scott DJ; Napadow V; Gracely RH; Clauw DJ
    Neuroimage; 2009 Sep; 47(3):1077-85. PubMed ID: 19501658
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Feeding Releases Endogenous Opioids in Humans.
    Tuulari JJ; Tuominen L; de Boer FE; Hirvonen J; Helin S; Nuutila P; Nummenmaa L
    J Neurosci; 2017 Aug; 37(34):8284-8291. PubMed ID: 28747384
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Opioid Release after High-Intensity Interval Training in Healthy Human Subjects.
    Saanijoki T; Tuominen L; Tuulari JJ; Nummenmaa L; Arponen E; Kalliokoski K; Hirvonen J
    Neuropsychopharmacology; 2018 Jan; 43(2):246-254. PubMed ID: 28722022
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Replacement of current opioid drugs focusing on MOR-related strategies.
    Busserolles J; Lolignier S; Kerckhove N; Bertin C; Authier N; Eschalier A
    Pharmacol Ther; 2020 Jun; 210():107519. PubMed ID: 32165137
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Molecular mechanisms of placebo responses in humans.
    Peciña M; Zubieta JK
    Mol Psychiatry; 2015 Apr; 20(4):416-23. PubMed ID: 25510510
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Risk for opioid misuse in chronic pain patients is associated with endogenous opioid system dysregulation.
    Ballester J; Baker AK; Martikainen IK; Koppelmans V; Zubieta JK; Love TM
    Transl Psychiatry; 2022 Jan; 12(1):20. PubMed ID: 35022382
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Investigation of [
    Kelleher AC; Pearson TD; Ramsey J; Zhao W; O'Conor KA; Bakhoda A; Stodden T; Guo M; Eisenberg SM; Shah SV; Freaney ML; Kim W; Kang Y; Tomasi D; Johnson C; Fang CA; Volkow ND; Kim SW
    Sci Rep; 2024 Jul; 14(1):16250. PubMed ID: 39009645
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Regulation of human affective responses by anterior cingulate and limbic mu-opioid neurotransmission.
    Zubieta JK; Ketter TA; Bueller JA; Xu Y; Kilbourn MR; Young EA; Koeppe RA
    Arch Gen Psychiatry; 2003 Nov; 60(11):1145-53. PubMed ID: 14609890
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Blunted endogenous opioid release following an oral dexamphetamine challenge in abstinent alcohol-dependent individuals.
    Turton S; Myers JF; Mick I; Colasanti A; Venkataraman A; Durant C; Waldman A; Brailsford A; Parkin MC; Dawe G; Rabiner EA; Gunn RN; Lightman SL; Nutt DJ; Lingford-Hughes A
    Mol Psychiatry; 2020 Aug; 25(8):1749-1758. PubMed ID: 29942043
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Blunted Endogenous Opioid Release Following an Oral Amphetamine Challenge in Pathological Gamblers.
    Mick I; Myers J; Ramos AC; Stokes PR; Erritzoe D; Colasanti A; Gunn RN; Rabiner EA; Searle GE; Waldman AD; Parkin MC; Brailsford AD; Galduróz JC; Bowden-Jones H; Clark L; Nutt DJ; Lingford-Hughes AR
    Neuropsychopharmacology; 2016 Jun; 41(7):1742-50. PubMed ID: 26552847
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Interindividual variability and lateralization of μ-opioid receptors in the human brain.
    Kantonen T; Karjalainen T; Isojärvi J; Nuutila P; Tuisku J; Rinne J; Hietala J; Kaasinen V; Kalliokoski K; Scheinin H; Hirvonen J; Vehtari A; Nummenmaa L
    Neuroimage; 2020 Aug; 217():116922. PubMed ID: 32407992
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Basal μ-opioid receptor availability in the amygdala predicts the inhibition of pain-related brain activity during heterotopic noxious counter-stimulation.
    Piché M; Watanabe N; Sakata M; Oda K; Toyohara J; Ishii K; Ishiwata K; Hotta H
    Neurosci Res; 2014; 81-82():78-84. PubMed ID: 24583336
    [TBL] [Abstract][Full Text] [Related]  

  • 39. It still hurts: altered endogenous opioid activity in the brain during social rejection and acceptance in major depressive disorder.
    Hsu DT; Sanford BJ; Meyers KK; Love TM; Hazlett KE; Walker SJ; Mickey BJ; Koeppe RA; Langenecker SA; Zubieta JK
    Mol Psychiatry; 2015 Feb; 20(2):193-200. PubMed ID: 25600108
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Intranasal naloxone rapidly occupies brain mu-opioid receptors in human subjects.
    Johansson J; Hirvonen J; Lovró Z; Ekblad L; Kaasinen V; Rajasilta O; Helin S; Tuisku J; Sirén S; Pennanen M; Agrawal A; Crystal R; Vainio PJ; Alho H; Scheinin M
    Neuropsychopharmacology; 2019 Aug; 44(9):1667-1673. PubMed ID: 30867551
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.